Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Clean Energy Investors Eye Nel ASA’s Cost Efficiency Plans

Hydrogen-related equities gained momentum following Nel ASA’s update on cost reduction efforts, reinforcing confidence in the clean energy space. Shares of companies involved in green hydrogen and electrolyzer manufacturing climbed as leadership indicated operational improvements might bolster profitability without depending on rising commodity prices. …

Vinay Lochav | 16 July 2026

Kalshi Odds: Traders Give Bitcoin a 54% Chance of Topping $67,500 in July

The contract asking whether Bitcoin will trade above $67,500 at any point in July is currently priced at 54%, meaning the market sees this as slightly more likely than not. That contract pays out at 1.79 times the stake if it resolves yes, a …

Nitish Kishor | 16 July 2026

Imperial Oil (TSX: IMO) Misses Q1 Earnings Estimates

Imperial Oil (TSX: IMO) released its first‑quarter financial results, revealing earnings that fell short of the consensus view held by analysts. The shortfall comes after a period of strong investor enthusiasm, during which the stock has outperformed many peers in the energy sector. While …

Vinay Lochav | 16 July 2026

Iran Summons UK Envoy Over Terrorist Designation, Market Tension Rises

Iran’s foreign ministry summoned the United Kingdom’s ambassador in Tehran to convey strong opposition to the recent terrorist designation of its security militia. The action follows a series of Western measures targeting the group, which Tehran views as an infringement on its sovereign security …

Vinay Lochav | 16 July 2026

Sable Offshore (NYSE: SOC) Price Target Slashed to $11, Still 180% Upside

Sable Offshore Corp (NYSE: SOC) saw Jefferies analyst Lloyd Byrne lower its price target from $24 to $11 on July 6, a 54% reduction. The new $11 target still suggests upside of over 180% versus the current trading price, and Jefferies retained a Buy …

Vinay Lochav | 16 July 2026

US Gasoline Prices Poised to Hit $4 Again, Pressuring Consumer Spending

US gasoline prices are on track to return to $4 per gallon, a shift that threatens to reignite inflation pressures and reshape sector performance across the economy. After months of relative stability, rising crude oil costs and seasonal demand are converging to push pump …

Vinay Lochav | 16 July 2026

Fermi Inc. (NASDAQ: FRMI) Raises $431M in Convertible Notes With 5% Coupon, Capped Call

Fermi Inc. has secured a sizeable new capital infusion through a convertible debt offering, reinforcing its balance sheet as it advances its AI‑focused power infrastructure. The securities, which bear a cash interest rate of 5.00% and mature in 2031, incorporate a capped‑call feature designed …

Vinay Lochav | 16 July 2026

Granite Ridge Resources (NYSE: GRNT): Undervalued Energy Stock GRNT Gains After Outperform Rating, Strong Production Growth

Granite Ridge Resources (NYSE: GRNT) received an Outperform rating from Northland Capital Markets, pushing its shares up 1.5% in pre-market trading to $4.64. Analyst Jeff Grampp set a $9 price target for the energy producer, emphasizing the company’s recent production growth. Despite this operational …

Vinay Lochav | 16 July 2026

Why CoreWeave (NASDAQ: CRWV) Is Quietly Preparing to Bet Against Its Own Memory Chip Suppliers

Key HighlightsCoreWeave (NASDAQ: CRWV)has reportedly held early, internal discussions about using derivatives, such as put options on memory-chip stocks, to hedge against a future drop in memory prices.The company has separately signed long-term supply contracts with Micron and SanDisk that include price floors, guaranteeing …

Nitish Kishor | 16 July 2026

Biotech Capital Strategy 2026: Arbutus Biopharma's $230M Return, Virax Biolabs' Compliance Restoration, and Galmed's LNP Partnership Signal Divergent Paths

Three small-cap biotechs reported significant corporate developments in the same period that collectively illustrate the diverse capital allocation strategies available to life sciences companies at different stages of commercial and financial development: Arbutus Biopharma (NASDAQ: ABUS) returning capital from IP monetization, Virax Biolabs (NASDAQ: …

Nitish Kishor | 16 July 2026
Support

Hi! How can we help you today?

Loading…